A prospective study of adjuvant CMF in males with node positive breast cancer: 20-year follow-up

Janice M. Walshe; Arlene W. Berman; Ujala Vatas; Seth M. Steinberg; William F. Anderson; Marc E. Lippman; Sandra M. Swain

首页> 外文期刊>Breast Cancer Research and Treatment >A prospective study of adjuvant CMF in males with node positive breast cancer: 20-year follow-up

【24h】

A prospective study of adjuvant CMF in males with node positive breast cancer: 20-year follow-up

机译：淋巴结阳性男性男性辅助性CMF的前瞻性研究：20年随访

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Purpose To determine the long-term overall survival of male patients with stage II node positive breast cancer treated with adjuvant chemotherapy.

机译：目的确定接受辅助化疗的男性II期淋巴结阳性乳腺癌男性患者的长期总体生存率。

著录项

来源
《Breast Cancer Research and Treatment》 |2007年第2期|177-183|共7页
作者
Janice M. Walshe; Arlene W. Berman; Ujala Vatas; Seth M. Steinberg; William F. Anderson; Marc E. Lippman; Sandra M. Swain;
展开▼
作者单位

Breast Cancer Section Medical Oncology Branch Center for Cancer Research National Cancer Institute National Institutes of Health Building 8 Rm 5101 8901 Wisconsin Ave Bethesda MD 20889 USA;

Breast Cancer Section Medical Oncology Branch Center for Cancer Research National Cancer Institute National Institutes of Health Building 8 Rm 5101 8901 Wisconsin Ave Bethesda MD 20889 USA;

Breast Cancer Section Medical Oncology Branch Center for Cancer Research National Cancer Institute National Institutes of Health Building 8 Rm 5101 8901 Wisconsin Ave Bethesda MD 20889 USA;

Biostatistics and Data Management Section National Cancer Institute National Institutes of Health Bethesda MD 20889 USA;

Division of Cancer Epidemiology ampamp Genetics National Cancer Institute National Institutes of Health Bethesda MD 20889 USA;

University of Michigan Ann Arbor MI 48109 USA;

Breast Cancer Section Medical Oncology Branch Center for Cancer Research National Cancer Institute National Institutes of Health Building 8 Rm 5101 8901 Wisconsin Ave Bethesda MD 20889 USA;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词
Adjuvant chemotherapy; CMF chemotherapy; Male breast cancer;

机译：辅助化疗;CMF化疗;男性乳腺癌;

相似文献

外文文献
中文文献
专利

1. A prospective study of adjuvant CMF in males with node positive breast cancer: 20-year follow-up. [J] . Walshe JM, Berman AW, Vatas U, Breast cancer research and treatment. . 2007,第2期

机译：男性淋巴结阳性乳腺癌佐剂CMF的前瞻性研究：20年随访。
2. Adjuvant CMFVP versus adjuvant CMFVP plus ovariectomy for premenopausal, node-positive, and estrogen receptor-positive breast cancer patients: a Southwest Oncology Group study. [J] . Rivkin SE, Green S, OSullivan J, Journal of Clinical Oncology . 1996,第1期

机译：绝经前，淋巴结阳性和雌激素受体阳性乳腺癌患者的辅助CMFVP与辅助CMFVP联合卵巢切除术：西南肿瘤小组的一项研究。
3. Cyclophosphamide, methotrexate and fluorouracil (CMF) versus hormonal ablation with leuprorelin acetate as adjuvant treatment of node-positive, premenopausal breast cancer patients: preliminary results of the TABLE-study (Takeda Adjuvant Breast cance [J] . Schmid Peter, Untch Michael, Wallwiener Diethelm, Anticancer Research: International Journal of Cancer Research and Treatment . 2002,第4期

机译：环磷酰胺，甲氨蝶呤和氟尿嘧啶（CMF）对比激素消融联合醋酸亮丙瑞林作为淋巴结阳性，绝经前乳腺癌患者的辅助治疗：TABLE研究的初步结果（武田辅助乳癌
4. Elevated WBP2 Expression in HER2-Positive Breast Cancers Correlates with Sensitivity to Trastuzumab-Based Neo-Adjuvant Therapy: A Retrospective and Multicentric Study [C] . Yoon Pin Lim International Molecular Medicine Tri-Conference. . 2019

机译：HER2阳性乳腺癌中的WBP2表达升高与基于曲妥珠单抗的新辅助治疗的敏感性相关：回顾性和多中心研究
5. Evaluation of pathologic parameters and published nomograms in predicting non-sentinel lymph node metastases in female breast cancer patients with positive sentinel lymph nodes. [D] . Murch, Lisa Elaine. 2007

机译：在前哨淋巴结阳性的女性乳腺癌患者中预测非前哨淋巴结转移的病理参数和公布的列线图评估。
6. A randomised factorial trial of sequential doxorubicin and CMF vs CMF and chemotherapy alone vs chemotherapy followed by goserelin plus tamoxifen as adjuvant treatment of node-positive breast cancer [O] . S De Placido, M De Laurentiis, M De Lena, 2005

机译：序贯阿霉素和CMF对比CMF单独化疗与化疗联合戈舍瑞林加他莫昔芬作为淋巴结阳性乳腺癌辅助治疗的随机因子分析
7. Randomized phase III trial of adjuvant epirubicin followed by cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) versus CMF followed by epirubicin in patients with node-negative or 1-3 node-positive rapidly proliferating breast cancer [O] . Amadori, D, Silvestrini, R, De Lena, M, 2011

机译：淋巴结阴性或1-3淋巴结阳性快速增生乳腺癌患者中佐剂表柔比星，环磷酰胺，甲氨蝶呤和5-氟尿嘧啶（CMF）与CMF联合表柔比星的III期随机试验

A prospective study of adjuvant CMF in males with node positive breast cancer: 20-year follow-up

摘要

著录项

相似文献

相关主题

期刊订阅